Impact News +++ Why GoPro Stock Skyrocketed This Week (Fool) +++ GOPRO Aktie +3,33%

VANDA Aktie

>VANDA Aktienkurs

4.05 EUR (Tradegate)

Ask: 4.12 EUR / 540 Stück

Bid: 3.98 EUR / 560 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

VANDA Aktie über LYNX handeln

Intraday

1 Jahr

>VANDA Performance

1 Woche: -0,5%

1 Monat: 0%

3 Monate: +5,5%

6 Monate: -11,8%

1 Jahr: -14,2%

laufendes Jahr: -11,6%

>VANDA Aktie

Name:

VANDA PHARMACEUTICALS

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US9216591084 / A0JJT3

Symbol/ Ticker:

VM4 (Frankfurt) / VNDA (NASDAQ)

Kürzel:

FRA:VM4, ETR:VM4, VM4:GR, NASDAQ:VNDA

Index:

Webseite:

https://www.vandapharma.c..

Profil:

Vanda Pharmaceuticals Inc. is a biopharmaceutical ..
>Volltext..

Marktkapitalisierung:

239.18 Mio. EUR

Unternehmenswert:

-27.1 Mio. EUR

Umsatz:

174.12 Mio. EUR

EBITDA:

-79.48 Mio. EUR

Nettogewinn:

-57.28 Mio. EUR

Gewinn je Aktie:

-0.98 EUR

Schulden:

9.96 Mio. EUR

Liquide Mittel:

69.3 Mio. EUR

Operativer Cashflow:

-55.45 Mio. EUR

Bargeldquote:

2.68

Umsatzwachstum:

1.64%

Gewinnwachstum:

-457.01%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

1 Insider kaufte innerhalb der letzten 30 Tage Aktien im Wert von 41.500 USD.

Suchwörter:

VANDA

Letzte Datenerhebung:

30.08.25

>VANDA Kennzahlen

Aktien/ Unternehmen:

Aktien: 59.09 Mio. St.

Frei handelbar: 93.12%

Leerverk. Aktien: 7.91%

Rückkaufquote: -

Mitarbeiter: 368

Umsatz/Mitarb.: 0.46 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 178.22%

Bewertung:

KGV: -

KGV lG: -

KUV: 1.35

KBV: 0.58

PEG-Ratio: -0.01

EV/EBITDA: -

Rentabilität:

Bruttomarge: 90.95%

Gewinnmarge: -32.9%

Operative Marge: -49.55%

Managementeffizenz:

Gesamtkaprendite: -10.49%

Eigenkaprendite: -13.01%

>VANDA Peer Group

Es sind 601 Aktien bekannt.

>VANDA Chart & Kurs - NASDAQ

>VANDA News

28.08.25 - 23:27	Vanda Pharmaceuticals Announces Participation at September 2025 Investor Conferences (PR Newswire)
	WASHINGTON, Aug. 28, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the following upcoming investor conferences in September 2025: The Cantor Global Healthcare Conference 2025 in New York City on Wednesday,......

28.08.25 - 16:12	Vanda Pharmaceuticals gets FDA orphan drug status for VGT-1849B (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

28.08.25 - 13:03	Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera (PR Newswire)
	WASHINGTON, Aug. 28, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for VGT-1849B, a selective peptide nucleic acid-based JAK2 inhibitor for the treatment of......

27.08.25 - 08:48

Hari: Tariffs Won′t Stop India from Buying Russian Oil (Bloomberg)

Additional US tariffs on Indian goods have come into effect on August 27, doubling the existing 25% duty imposed on August 7 to 50%. Meanwhile oil held a large drop as investors weighed the fallout from higher tariffs over India's imports of Russian crude. Vandana Hari, Founder of VANDA Insights told Bloomberg's Horizons Middle East and Africa anchor Joumanna Bercetche there's no signs the tariffs will have a major shift in local refiners' purchasing patterns. (Source: Bloomberg)...

21.08.25 - 23:39	Vanda asks FDA′s Makary to review approval of Hetlioz generics (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

21.08.25 - 22:42	Vanda Seeks FDA Commissioner Review of Outgoing CDER Director′s Decision to Uphold Approval of Two Generic Versions of Hetlioz® (PR Newswire)
	WASHINGTON, Aug. 21, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has asked Martin Makary, the Commissioner of the U.S. Food and Drug Administration (FDA) to review the decision made by Jacqueline Corrigan-Curay, the departing director of......

18.08.25 - 15:09	Vanda says court ruling opens door for Hetlioz jet lag indication (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

18.08.25 - 13:03	In a Major Win for Vanda, a Federal Appeals Court Overturns FDA′s Order Denying Approval of Hetlioz for the Treatment of Jet Lag Disorder (PR Newswire)
	WASHINGTON, Aug. 18, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it secured a landmark victory over the U.S. Food and Drug Administration (FDA) in its longstanding dispute with the agency regarding the approvability of HETLIOZ® (tasimelteon)......

08.08.25 - 23:01	Insiderhandel: President and CEO kauft Aktien von Vanda Pharmaceuticals im Wert von 41500 USD (Insiderkauf)
	Polymeropoulos, Mihael Hristos - Vorstand - Tag der Transaktion: 2025-08-07...

04.08.25 - 08:18

Modi Defiant as Trump Steps Up Pressure on Russian Oil Purchases (Bloomberg)

Indian Prime Minister Narendra Modi has underscored the importance of shielding the country's economic interests during uncertain global conditions. His comments came just days after the Trump administration imposed a 25% tariff on Indian exports to the US. The White House is also threatening more action if India continues Russian oil purchases. Vanda Insights founder Vandana Hari and Bloomberg's Ruchi Bhatia discuss the details. (Source: Bloomberg)...

01.08.25 - 11:00	Vanda (VNDA) Q2 Revenue Rises 4% (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

31.07.25 - 16:00	Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
	Vanda (VNDA) delivered earnings and revenue surprises of -35.29% and -4.38%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...

31.07.25 - 13:45	Vanda Pharmaceuticals misses top-line and bottom-line estimates; reaffirms FY25 outlook (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

31.07.25 - 13:33	Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results (PR Newswire)
	Fanapt® Q2 2025 net product sales increased by 27% to $29.3 million compared to Q2 2024 Bysanti™ (milsaperidone) NDA for bipolar I disorder and schizophrenia accepted for filing; PDUFA target action date of February 21, 2026 Tradipitant NDA for motion sickness accepted for filing; PDUFA......

31.07.25 - 12:48	The meme-stock party is already fizzling out. What that means for the rest of the market. (MarketWatch)
	The meme-stock craze may have ended before it could flourish, caught up in a summer market and big tech earnings, says Vanda Research....

30.07.25 - 17:06	Vanda Pharmaceuticals Q2 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

23.07.25 - 22:48	Vanda Pharmaceuticals to Announce Second Quarter 2025 Financial Results on July 31, 2025 (PR Newswire)
	Conference Call and Webcast to Follow WASHINGTON, July 23, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the second quarter 2025 on Thursday, July 31, 2025, before the market opens. Vanda will host a conference call at......

17.06.25 - 11:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Vanda Pharmaceuticals im Wert von 32130 USD (Insiderkauf)
	Mitchell, Stephen Ray - Aufsichtsrat - Tag der Transaktion: 2025-06-13...

27.05.25 - 15:01	Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting (PR Newswire)
	WASHINGTON, May 27, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, to be held in Scottsdale, Arizona, from May 27 through May 30, 2025. The following will be......

22.05.25 - 07:01	Insiderhandel: President and CEO kauft Aktien von Vanda Pharmaceuticals im Wert von 43996 USD (Insiderkauf)
	Polymeropoulos, Mihael Hristos - Vorstand - Tag der Transaktion: 2025-05-21...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Was machst du an der Welt? Sie ist schon gemacht, der Herr der Schöpfung hat alles bedacht. - Johann Wolfgang von Goethe

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram